- Ginkgo snaps up gene therapy vector assets from StrideBio Endpoints News
- Ginkgo, hunting for biotech platforms that ‘collect dust,’ scoops up AAV gene therapy capsid specialist FierceBiotech
- Ginkgo Bioworks Strengthens End-to-End R&D Capabilities in Gene Therapy through Acquisition of StrideBio’s AAV Capsid Discovery and Engineering Platform Assets PR Newswire
- Sensible Biotechnologies Partners with Ginkgo to Develop Novel mRNA Manufacturing Platform Genetic Engineering & Biotechnology News
- Solvay, Gingko collaborate on sustainable biotechnology Food Business News
- View Full Coverage on Google News
Read original article here